The association of ADT and Alzheimer’s disease is supported by a number of plausible biologic mechanisms including through augmentation of β-amyloid protein levels11, interaction with the Apolipoprotein E gene12, a direct neuropathic effect13 and an increase in cardiometabolic disease5, 14. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.